Sofosbuvir protects human brain organoids against SARS-CoV-2
Pinar Mesci, Ángela Macia, Aurian Saleh, Laura Martin‐Sancho, Xin Yin, Cedric E. Snethlage, Simoni Helena Avansini, Sumit K. Chanda, Alysson Renato Muotri
SARS-CoV-2 infects and kills neural cells in iPSC-derived human brain organoids and impairs synaptogenesis; the approved antiviral sofosbuvir is reported to reverse both effects.
bioRxiv · May 30, 2020 · PreprintNeuroscience